期刊文献+

Clinical Research on the Changes of Plasma TFPI and uPA System in Malignant Tumor

恶性肿瘤患者血浆TFPI和uPA系统变化的临床研究(英文)
暂未订购
导出
摘要 Objective: To investigate the expression levels and significance of TFPI, uPA, uPAR and PAI in malignant patients. Methods: The levels of TFPI, uPA and uPAR were measured by using ELISA and the level of PAI was determined by method of chromogenic substrates in 44 patients with malignant solid tumors (group A1) and 30 patients with acute leukemia (AL, group A2). Results: The levels of TFPI, uPA, and uPAR in group A1 were higher than those in normal control group (group B). TFPI, uPAR levels in group A2 were higher than those in group B, while the level of PAI in group A2 was lower than that in group B. Among the groups, TFPI was increased in the combined infection group; PAI decreased in the hemorrhage group; TFPI, uPA, uPAR and PAI increased in relapsing and metastasis group; TFPI decreased in one-week dead group, while uPA and uPAR increased. Conclusion: The patients with malignant solid tumor and AL had different anticoagulation or fibrinolysis states. TFPI, uPA, Upar and PAI can be used to evaluate the disease condition and the prognosis.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2004年第2期78-80,124,共4页 中德临床肿瘤学杂志(英文版)
关键词 malignant tumor acute leukemia tissue factor pathway inhibitor urokinase plasminogen 恶性肿瘤 血浆TFPI uPA系统 组织因子途径抑制物 尿激酶型纤溶酶原激活系统
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部